A link between the fibroblast growth factor axis and the miR-16 family reveals potential new treatment combinations in mesothelioma
出版年份 2017 全文链接
标题
A link between the fibroblast growth factor axis and the miR-16 family reveals potential new treatment combinations in mesothelioma
作者
关键词
-
出版物
Molecular Oncology
Volume 12, Issue 1, Pages 58-73
出版商
Wiley
发表日期
2017-11-02
DOI
10.1002/1878-0261.12150
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The inhibition of FGF receptor 1 activity mediates sorafenib antiproliferative effects in human malignant pleural mesothelioma tumor-initiating cells
- (2017) Alessandra Pattarozzi et al. Stem Cell Research & Therapy
- Co-targeting of FAK and MDM2 triggers additive anti-proliferative effects in mesothelioma via a coordinated reactivation of p53
- (2016) Wen-Bin Ou et al. BRITISH JOURNAL OF CANCER
- Cationic microRNA-delivering nanocarriers for efficient treatment of colon carcinoma in xenograft model
- (2016) G Liang et al. GENE THERAPY
- Differential microRNA expression profiling of mesothelioma and expression analysis of miR-1 and miR-214 in mesothelioma
- (2016) VISHWA JEET AMATYA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Trabectedin Is Active against Malignant Pleural Mesothelioma Cell and Xenograft Models and Synergizes with Chemotherapy and Bcl-2 Inhibition In Vitro
- (2016) M. A. Hoda et al. MOLECULAR CANCER THERAPEUTICS
- Inhibition of FGF/FGFR autocrine signaling in mesothelioma with the FGF ligand trap, FP-1039/GSK3052230
- (2016) Christina Blackwell et al. Oncotarget
- BCL-2 inhibition impairs mitochondrial function and targets oral tongue squamous cell carcinoma
- (2016) Lei Xiong et al. SpringerPlus
- A Significant Metabolic and Radiological Response after a Novel Targeted MicroRNA-based Treatment Approach in Malignant Pleural Mesothelioma
- (2015) Steven C. Kao et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- FGFR1 Expression Levels Predict BGJ398 Sensitivity of FGFR1-Dependent Head and Neck Squamous Cell Cancers
- (2015) F. Goke et al. CLINICAL CANCER RESEARCH
- Loss of miR-223 and JNK Signaling Contribute to Elevated Stathmin in Malignant Pleural Mesothelioma
- (2015) K. A. Birnie et al. MOLECULAR CANCER RESEARCH
- miR-16 targets fibroblast growth factor 2 to inhibit NPC cell proliferation and invasion via PI3K/AKT and MAPK signaling pathways
- (2015) Qingmei He et al. Oncotarget
- Predicting effective microRNA target sites in mammalian mRNAs
- (2015) Vikram Agarwal et al. eLife
- Fibroblast Growth Factor Receptor Inhibition Is Active against Mesothelioma and Synergizes with Radio- and Chemotherapy
- (2014) Karin Schelch et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- FGFR1 mRNA and Protein Expression, not Gene Copy Number, Predict FGFR TKI Sensitivity across All Lung Cancer Histologies
- (2014) M. W. Wynes et al. CLINICAL CANCER RESEARCH
- Diagnostic Potential of miR-126, miR-143, miR-145, and miR-652 in Malignant Pleural Mesothelioma
- (2014) Morten Andersen et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Nonamplified FGFR1 Is a Growth Driver in Malignant Pleural Mesothelioma
- (2014) Lindsay A. Marek et al. MOLECULAR CANCER RESEARCH
- The Fibroblast Growth Factor Receptor Genetic Status as a Potential Predictor of the Sensitivity to CH5183284/Debio 1347, a Novel Selective FGFR Inhibitor
- (2014) Y. Nakanishi et al. MOLECULAR CANCER THERAPEUTICS
- MET and PI3K/mTOR as a Potential Combinatorial Therapeutic Target in Malignant Pleural Mesothelioma
- (2014) Rajani Kanteti et al. PLoS One
- Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma
- (2013) G. Reid et al. ANNALS OF ONCOLOGY
- Downregulation of microRNA-214 and overexpression of FGFR-1 contribute to hepatocellular carcinoma metastasis
- (2013) Jian Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- miR-99a promotes proliferation targeting FGFR3 in human epithelial ovarian cancer cells
- (2013) Haiyang Jiang et al. BIOMEDICINE & PHARMACOTHERAPY
- Enhanced FGFR signalling predisposes pancreatic cancer to the effect of a potent FGFR inhibitor in preclinical models
- (2013) H Zhang et al. BRITISH JOURNAL OF CANCER
- ZIC1 Is Silenced and Has Tumor Suppressor Function in Malignant Pleural Mesothelioma
- (2013) Yuen Yee Cheng et al. Journal of Thoracic Oncology
- FGF Receptors: Cancer Biology and Therapeutics
- (2013) Masaru Katoh et al. MEDICINAL RESEARCH REVIEWS
- The ticking time-bomb of asbestos: Its insidious role in the development of malignant mesothelioma
- (2012) Anthony Linton et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- miR-34 – a microRNA replacement therapy is headed to the clinic
- (2012) Andreas G. Bader Frontiers in Genetics
- Identification of a Therapeutic Strategy Targeting Amplified FGF19 in Liver Cancer by Oncogenomic Screening
- (2011) Eric T. Sawey et al. CANCER CELL
- Fibroblast Growth Factor Receptors as Therapeutic Targets in Human Melanoma: Synergism with BRAF Inhibition
- (2011) Thomas Metzner et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- MicroRNAs Dysregulation in Human Malignant Pleural Mesothelioma
- (2011) Veronica Balatti et al. Journal of Thoracic Oncology
- Post-transcriptional and post-translational regulation of Bcl2: Figure 1
- (2010) Shaun Willimott et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Targeting Fibroblast Growth Factor Receptors Blocks PI3K/AKT Signaling, Induces Apoptosis, and Impairs Mammary Tumor Outgrowth and Metastasis
- (2010) J. H. Dey et al. CANCER RESEARCH
- hsa-miR-29c* Is Linked to the Prognosis of Malignant Pleural Mesothelioma
- (2010) H. I. Pass et al. CANCER RESEARCH
- A Phase II Study of Sorafenib in Malignant Mesothelioma: Results of Cancer and Leukemia Group B 30307
- (2010) Sarita Dubey et al. Journal of Thoracic Oncology
- Frequent and Focal FGFR1 Amplification Associates with Therapeutically Tractable FGFR1 Dependency in Squamous Cell Lung Cancer
- (2010) J. Weiss et al. Science Translational Medicine
- MicroRNAs in Cancer
- (2009) Ramiro Garzon et al. Annual Review of Medicine
- MiR-15a and MiR-16 Control Bmi-1 Expression in Ovarian Cancer
- (2009) R. Bhattacharya et al. CANCER RESEARCH
- miR-15a and miR-16 Are Implicated in Cell Cycle Regulation in a Rb-Dependent Manner and Are Frequently Deleted or Down-regulated in Non–Small Cell Lung Cancer
- (2009) Nora Bandi et al. CANCER RESEARCH
- The Role of Fibroblast Growth Factors in Tumor Growth
- (2009) M. Korc et al. CURRENT CANCER DRUG TARGETS
- Antibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in mice
- (2009) Jing Qing et al. JOURNAL OF CLINICAL INVESTIGATION
- Systemic Delivery of Synthetic MicroRNA-16 Inhibits the Growth of Metastatic Prostate Tumors via Downregulation of Multiple Cell-cycle Genes
- (2009) Fumitaka Takeshita et al. MOLECULAR THERAPY
- The Endothelial-Specific MicroRNA miR-126 Governs Vascular Integrity and Angiogenesis
- (2008) Shusheng Wang et al. DEVELOPMENTAL CELL
- The miR-15a–miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities
- (2008) Désirée Bonci et al. NATURE MEDICINE
- A neutralizing anti-fibroblast growth factor (FGF) 8 monoclonal antibody shows anti-tumor activity against FGF8b-expressing LNCaP xenografts in androgen-dependent and -independent conditions
- (2008) Kumiko Maruyama-Takahashi et al. PROSTATE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now